Split-Dose R-CHOP for Older Patients with Treatment Naive DLBCL

被引：0
|
作者：
Kidwell, Adam [1 ]
Furqan, Fateeha [2 ]
Aschenbrenner, Emilie [3 ]
Longo, Walter [4 ]
Devata, Sumana [3 ]
Hamadani, Mehdi [5 ]
Fenske, Timothy S. [2 ]
Shah, Nirav N. [6 ]
机构：
[1] Froedtert Hosp, Med Coll Wisconsin, Canc Ctr, Milwaukee, WI USA
[2] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[3] Med Coll Wisconsin, Milwakee, WI USA
[4] Med Coll Wisconsin, Div Hematol Oncol, Milwaukee, WI USA
[5] Med Coll Wisconsin Inc, Div Hematol & Oncol, Milwaukee, WI USA
[6] Froedtert Hosp, Med Coll Wisconsin, Canc Ctr, Brookfield, WI USA
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-203974
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2374 / 2375
页数：2
相关论文
共 50 条
  • [1] Split-dose R-CHOP: A novel approach to administer cytotoxic chemotherapy to geriatric patients with DLBCL
    Shah, Nirav
    Mitra, Nandita
    Brikman, Joshua
    Nasta, Sunita
    Landsburg, Daniel
    Mato, Anthony
    Vogl, Dan
    Frey, NoeIle
    Schuster, Stephen
    Svoboda, Jakub
    CANCER RESEARCH, 2015, 75
  • [2] Phase II trial of split-dose R-CHOP for older patients with diffuse large B-cell lymphoma (DLBCL)
    Shah, Nirav Niranjan
    Szabo, Aniko
    Rajguru, Saurabh
    Devata, Sumana
    Howard, Mitch
    Pereira, Deepa
    Endres, Mariah
    Longo, Walter L.
    Hamadani, Mehdi
    Fenske, Timothy S.
    Fletcher, Christopher David
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Split-dose R-CHOP: a new approach to administer cytotoxic chemo-immunotherapy to elderly patients with DLBCL
    Shah, Nirav N.
    Mitra, Nandita
    Brikman, Joshua
    Nasta, Sunita
    Landsburg, Daniel
    Mato, Anthony
    Vogl, Dan
    Frey, Noelle
    Schuster, Stephen J.
    Svoboda, Jakub
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2016, 14 (11): : 450 - 456
  • [4] 80% Dose R-CHOP Is Suitable Chemotherapy for Very Elderly Patients with DLBCL
    Takahashi, Anna
    Mishima, Yuko
    Inoue, Norihito
    Kusano, Yoshiharu
    Gunji, Tadahiro
    Ueda, Kyoko
    Nishimura, Noriko
    Nitta, Hideaki
    Yokoyama, Masahiro
    Tsuyama, Naoko
    Takeuchi, Kengo
    Terui, Yasuhito
    Hatake, Kiyohiko
    BLOOD, 2015, 126 (23)
  • [5] Impact of Total Dose Intensity and Relative Dose Intensity (RDI) of R-CHOP on Survival in Patients with DLBCL
    Komuro, Ayumi
    Seo, Sachiko
    Mochizuki, Nobuo
    Minami, Yosuke
    Kawasaki, Toshikatu
    BLOOD, 2018, 132
  • [6] The effect of R-CHOP dose reduction on overall survival of elderly patients with DLBCL - comparative study
    Vidal, Liat
    Lando, Shany
    Vaxman, Iuliana
    Shochat, Tzippy
    Raanani, Pia
    Gurion, Ronit
    Gafter-Gvili, Anat
    LEUKEMIA & LYMPHOMA, 2018, 59 (04) : 904 - 910
  • [7] Prognostic PET after R-CHOP in DLBCL
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (04) : 17N - 17N
  • [8] R-CHOP in DLBCL: priming for success Comment
    Hertzberg, Mark
    BLOOD, 2022, 139 (08) : 1121 - 1122
  • [9] Impact of Omission/Reduction of Vincristine From R-CHOP in Treatment of DLBCL
    Marshall, Shoko
    Nishimura, Noriko
    Inoue, Norihito
    Yamauchi, Hirofumi
    Tsuyama, Naoko
    Takeuchi, Kengo
    Mishima, Yuko
    Yokoyama, Masahiro
    Ogasawara, Toshie
    Mori, Naoki
    Ogawa, Tetsuya
    Sakura, Hiroshi
    Terui, Yasuhito
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (03): : 162 - 169
  • [10] IPI and R-IPI in Korean DLBCL patients treated with R-CHOP
    Bae, Sung-Hwa
    Ryoo, Hun-Mo
    Kim, Min Kyoung
    Lee, Kyung Hee
    Hyun, Myung Soo
    Kim, Hawk
    Park, Jea-Hoo
    Lee, Won-Sik
    Joo, Young-Don
    BLOOD, 2007, 110 (11) : 191B - 191B
12345